Skip to Content


In the US, Modafinil (modafinil systemic) is a member of the drug class CNS stimulants and is used to treat ADHD, Chronic Fatigue Syndrome, Depression, Fatigue, Hypersomnia, Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome and Shift Work Sleep Disorder.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Central stimulant

Sympathomimetic agent

Chemical Names

(RS)-2-[(Diephenylmetyl)sulfinyl]acetamid (IUPAC)

2-[(Diphenylmetyl)sulfinyl]acetamide (WHO)

Foreign Names

  • Modafinilum (Latin)
  • Modafinil (German)
  • Modafinil (French)
  • Modafinilo (Spanish)

Generic Names

  • Modafinil (OS: BAN, DCF, USAN, JAN)
  • CEP 1538 (IS)
  • CRL 40476 (IS)
  • Modafinil (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Modafinilum (PH: Ph. Eur. 8)

Brand Names

  • Alertec
    Shire, Canada
  • Alertex
    Eurolab, Chile; Saval, Ecuador
  • Altasomil
    Altamedics, Slovenia
  • Aspendos
    Medochemie, Bulgaria; Medochemie, Cyprus; Medochemie, Netherlands; Medochemie, Romania; Medochemie, Slovakia
  • Forcilin
    LKM, Argentina
  • Intensit
    AstraZeneca, Argentina
  • Mentix
    Royal Pharma, Chile
  • Modafinil Aurobindo
    Aurobindo, Malta; Aurobindo, Netherlands; Aurobindo Pharma - Milpharm, United Kingdom
  • Modafinil Biogaran
    Biogaran, France
  • Modafinil Bluefish
    Bluefish Pharma, Sweden; Bluefish Pharmaceuticals, Iceland
  • Modafinil Chanelle
    Chanelle, Netherlands
  • Modafinil EG
    EG Labo, France
  • Modafinil Generis
    Generis, Portugal
  • Modafinil Genus
    Genus Pharmaceuticals, United Kingdom
  • Modafinil Medochemie
    Medochemie, Netherlands
  • Modafinil Mylan
    Mylan, Denmark; Mylan, France; Mylan, Netherlands; Mylan, Sweden
  • Modafinil Orchid
    Orchid, Netherlands
  • Modafinil Teva
    Teva Pharmaceuticals, United Kingdom
  • Modafinil Wynn
    Wynn, Portugal
  • Modafinil-Acino
    Acino Pharma, Switzerland
  • Modafinil-neuraxpharm
    neuraxpharm, Germany
  • Modanil
    Hanmi, South Korea
  • Modasomil
    Teva Pharma, Austria; Teva Pharma, Switzerland
  • Modavigil
    bioCSL, New Zealand; CSL, Australia
  • Modiodal
    2care4, Norway; Alfresa Pharma, Japan; Cephalon, Netherlands; Cephalon, Tunisia; Euro Registratie, Netherlands; Gen, Turkey; Genesis, Greece; Lundbeck, Mexico; Medcor, Netherlands; MSD, Sweden; Noventure, Spain; Orifarm, Norway; Teva, Denmark; Teva, Iceland; Teva, Netherlands; Teva, Norway; Teva Pharma, Portugal; Teva Santé, France
  • Modiwake
    Generica, Turkey
  • Movigil
    Laboratorio Bago, Chile
  • Provigil
    Cephalon, United States; MSD Belgium, Belgium; P & D, Malta; Taiwan Biotech, Taiwan; Teva Italia, Italy; Teva Pharma, Israel; Teva Pharmaceuticals, United Kingdom
  • Resotyl
    Drugtech, Chile; Farmindustria, Peru
  • Stavigile
    Libbs, Brazil
  • Vigia
    Procaps, Colombia
  • Vigicer
    Beta, Argentina
  • Vigil
    Teva, Germany; Torrex, Czech Republic
  • Vigimax
    Laboratorios Pharmavita, Chile
  • Zalux
    Laboratorio Chile, Chile


BANBritish Approved Name
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.